These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 34410317)

  • 21. Optical Structural Analysis of Individual α-Synuclein Oligomers.
    Varela JA; Rodrigues M; De S; Flagmeier P; Gandhi S; Dobson CM; Klenerman D; Lee SF
    Angew Chem Int Ed Engl; 2018 Apr; 57(18):4886-4890. PubMed ID: 29342318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alpha-synuclein seeds in olfactory mucosa of patients with isolated REM sleep behaviour disorder.
    Stefani A; Iranzo A; Holzknecht E; Perra D; Bongianni M; Gaig C; Heim B; Serradell M; Sacchetto L; Garrido A; Capaldi S; Sánchez-Gómez A; Cecchini MP; Mariotto S; Ferrari S; Fiorini M; Schmutzhard J; Cocchiara P; Vilaseca I; Brozzetti L; Monaco S; Jose Marti M; Seppi K; Tolosa E; Santamaria J; Högl B; Poewe W; Zanusso G;
    Brain; 2021 May; 144(4):1118-1126. PubMed ID: 33855335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tau/α-synuclein ratio and inflammatory proteins in Parkinson's disease: An exploratory study.
    Delgado-Alvarado M; Gago B; Gorostidi A; Jiménez-Urbieta H; Dacosta-Aguayo R; Navalpotro-Gómez I; Ruiz-Martínez J; Bergareche A; Martí-Massó JF; Martínez-Lage P; Izagirre A; Rodríguez-Oroz MC
    Mov Disord; 2017 Jul; 32(7):1066-1073. PubMed ID: 28548309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study.
    Mollenhauer B; Locascio JJ; Schulz-Schaeffer W; Sixel-Döring F; Trenkwalder C; Schlossmacher MG
    Lancet Neurol; 2011 Mar; 10(3):230-40. PubMed ID: 21317042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. C-terminal truncation exacerbates the aggregation and cytotoxicity of α-Synuclein: A vicious cycle in Parkinson's disease.
    Ma L; Yang C; Zhang X; Li Y; Wang S; Zheng L; Huang K
    Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3714-3725. PubMed ID: 30290273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of cerebrospinal fluid β-amyloid 1-42, T-tau, P-tau181, and α-synuclein levels with clinical features of drug-naive patients with early Parkinson disease.
    Kang JH; Irwin DJ; Chen-Plotkin AS; Siderowf A; Caspell C; Coffey CS; Waligórska T; Taylor P; Pan S; Frasier M; Marek K; Kieburtz K; Jennings D; Simuni T; Tanner CM; Singleton A; Toga AW; Chowdhury S; Mollenhauer B; Trojanowski JQ; Shaw LM;
    JAMA Neurol; 2013 Oct; 70(10):1277-87. PubMed ID: 23979011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Broad neutralization of calcium-permeable amyloid pore channels with a chimeric Alzheimer/Parkinson peptide targeting brain gangliosides.
    Di Scala C; Yahi N; Flores A; Boutemeur S; Kourdougli N; Chahinian H; Fantini J
    Biochim Biophys Acta; 2016 Feb; 1862(2):213-22. PubMed ID: 26655601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Formation of amyloid fibrils by the regulatory 14-3-3
    Šulskis D; Žiaunys M; Sakalauskas A; Sniečkutė R; Smirnovas V
    Open Biol; 2024 Jan; 14(1):230285. PubMed ID: 38228169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parkinson's disease is a type of amyloidosis featuring accumulation of amyloid fibrils of α-synuclein.
    Araki K; Yagi N; Aoyama K; Choong CJ; Hayakawa H; Fujimura H; Nagai Y; Goto Y; Mochizuki H
    Proc Natl Acad Sci U S A; 2019 Sep; 116(36):17963-17969. PubMed ID: 31427526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amyloid aggregates of the deubiquitinase OTUB1 are neurotoxic, suggesting that they contribute to the development of Parkinson's disease.
    Kumari R; Kumar R; Kumar S; Singh AK; Hanpude P; Jangir D; Maiti TK
    J Biol Chem; 2020 Mar; 295(11):3466-3484. PubMed ID: 32005664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tear α-synuclein as a biomarker for Parkinson's disease: A systematic review and meta-analysis.
    Akowuah PK; Owusu E; Totoe D
    Optom Vis Sci; 2024 Jul; 101(7):485-492. PubMed ID: 39094023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct Observation of α-Synuclein Amyloid Aggregates in Endocytic Vesicles of Neuroblastoma Cells.
    Apetri MM; Harkes R; Subramaniam V; Canters GW; Schmidt T; Aartsma TJ
    PLoS One; 2016; 11(4):e0153020. PubMed ID: 27105068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High Selectivity and Sensitivity of Oligomeric p-Phenylene Ethynylenes for Detecting Fibrillar and Prefibrillar Amyloid Protein Aggregates.
    Fanni AM; Monge FA; Lin CY; Thapa A; Bhaskar K; Whitten DG; Chi EY
    ACS Chem Neurosci; 2019 Mar; 10(3):1813-1825. PubMed ID: 30657326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cofilin 1 promotes the aggregation and cell-to-cell transmission of α-synuclein in Parkinson's disease.
    Yan M; Meng L; Dai L; Zhang X; Chen G; Zheng Y; Zha Y; Zeng Y; Zhang Z
    Biochem Biophys Res Commun; 2020 Sep; 529(4):1053-1060. PubMed ID: 32819564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of neuron-derived pathological α-synuclein in blood.
    Kluge A; Bunk J; Schaeffer E; Drobny A; Xiang W; Knacke H; Bub S; Lückstädt W; Arnold P; Lucius R; Berg D; Zunke F
    Brain; 2022 Sep; 145(9):3058-3071. PubMed ID: 35722765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In Vitro Analysis of α-Synuclein Amyloid Formation and Cross-Reactivity.
    Horvath I; Rocha S; Wittung-Stafshede P
    Methods Mol Biol; 2018; 1779():73-83. PubMed ID: 29886528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroinflammation and protein pathology in Parkinson's disease dementia.
    Kouli A; Camacho M; Allinson K; Williams-Gray CH
    Acta Neuropathol Commun; 2020 Dec; 8(1):211. PubMed ID: 33272323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Faster disease progression in Parkinson's disease with type 2 diabetes is not associated with increased α-synuclein, tau, amyloid-β or vascular pathology.
    de Pablo-Fernández E; Courtney R; Rockliffe A; Gentleman S; Holton JL; Warner TT
    Neuropathol Appl Neurobiol; 2021 Dec; 47(7):1080-1091. PubMed ID: 33969516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Baseline concentration of misfolded α-synuclein aggregates in cerebrospinal fluid predicts risk of cognitive decline in Parkinson's disease.
    Ning H; Wu Q; Han D; Yao T; Wang J; Lu W; Lv S; Jia Q; Li X
    Neuropathol Appl Neurobiol; 2019 Jun; 45(4):398-409. PubMed ID: 30346044
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An 11-mer Amyloid Beta Peptide Fragment Provokes Chemical Mutations and Parkinsonian Biomarker Aggregation in Dopaminergic Cells: A Novel Road Map for "Transfected" Parkinson's.
    Kabiraj P; Marin JE; Varela-Ramirez A; Narayan M
    ACS Chem Neurosci; 2016 Nov; 7(11):1519-1530. PubMed ID: 27635664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.